Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities
- PMID: 28938958
- DOI: 10.1016/j.ahj.2017.06.006
Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities
Abstract
Objective: The current understanding of pulmonary hypertension (PH) due to left ventricular diseases does not distinguish heart failure (HF) with reduced ejection fraction (HFrEF) from HF and preserved ejection fraction (HFpEF), in terms of pulmonary hemodynamics. The value of pulmonary vascular compliance (PCa) and diastolic pulmonary gradient (DPG) as predictors of survival in either HF syndrome is controversial. The aims of our study were to compare the pulmonary hemodynamics in the two HF phenotypes, given similar values of pulmonary artery wedge pressure (PAWP), and to evaluate the impact of PCa and DPG on survival.
Methods: We retrospectively reviewed the charts of 168 PH-HFrEF and 86 PH-HFpEF patients. The independent association of PCa and DPG with prognosis was assessed by means of a Cox proportional hazard model. All cause survival was analyzed over an average follow-up period of 50 months.
Results: PH-HFpEF patients had a significantly higher DPG than PH-HFrEF patients (6.1±7.1 vs 1.8±4.5 mmHg, adjusted P=.025). PCa was similar in PH-HFpEF and PH-HFrEF. PCa was a significant predictor of survival, according to previously described preset cutoffs (2.15 mL/mmHg in HFrEF and 1.1 mL/mmHg in HFpEF) and based on a continuous scale; whereas DPG had no impact on survival in both patients groups.
Conclusion: Our findings suggest that for similar levels of PAWP, pulmonary circulation may be stiffer in patients with HFpEF-PH than patients with HFrEF-PH, leading to higher DPGs. Nonetheless, PCa rather than DPG emerged as the stronger predictor of survival in both left-sided PH phenotypes.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.Eur J Heart Fail. 2017 Dec;19(12):1664-1671. doi: 10.1002/ejhf.873. Epub 2017 Jun 8. Eur J Heart Fail. 2017. PMID: 28597497
-
Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.J Am Coll Cardiol. 2012 Jan 31;59(5):442-51. doi: 10.1016/j.jacc.2011.09.062. J Am Coll Cardiol. 2012. PMID: 22281246
-
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16. Eur J Heart Fail. 2018. PMID: 29148140
-
Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.J Am Coll Cardiol. 2020 Sep 1;76(9):1102-1111. doi: 10.1016/j.jacc.2020.06.069. J Am Coll Cardiol. 2020. PMID: 32854845 Review.
-
Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.Trends Cardiovasc Med. 2019 May;29(4):207-217. doi: 10.1016/j.tcm.2018.08.005. Epub 2018 Aug 17. Trends Cardiovasc Med. 2019. PMID: 30177249 Free PMC article. Review.
Cited by
-
Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.Curr Heart Fail Rep. 2018 Apr;15(2):81-93. doi: 10.1007/s11897-018-0377-9. Curr Heart Fail Rep. 2018. PMID: 29417467 Review.
-
The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure.Front Cardiovasc Med. 2023 May 18;10:1125014. doi: 10.3389/fcvm.2023.1125014. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37273885 Free PMC article. Review.
-
Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management.Int J Mol Sci. 2023 Jun 9;24(12):9971. doi: 10.3390/ijms24129971. Int J Mol Sci. 2023. PMID: 37373119 Free PMC article. Review.
-
Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.J Physiol. 2019 Feb;597(4):1143-1156. doi: 10.1113/JP275858. Epub 2018 Dec 30. J Physiol. 2019. PMID: 30549058 Free PMC article. Review.
-
Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study.Eur Heart J. 2024 Sep 14;45(35):3274-3288. doi: 10.1093/eurheartj/ehae467. Eur Heart J. 2024. PMID: 39056467 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous